O	0	1	[	[	(	O
O	1	12	Interleukin	Interleukin	NN	B-NP
O	12	13	-	-	HYPH	O
O	13	15	18	18	CD	B-NP
O	16	19	and	and	CC	O
O	20	23	new	new	JJ	B-NP
O	24	29	drugs	drug	NNS	I-NP
O	29	30	.	.	.	O
O	31	41	Protective	Protective	JJ	B-NP
O	42	48	effect	effect	NN	I-NP
O	49	56	against	against	IN	B-PP
B-Cancer	57	62	tumor	tumor	NN	B-NP
O	63	69	growth	growth	NN	I-NP
O	70	73	and	and	CC	I-NP
O	74	84	infections	infection	NNS	I-NP
O	84	85	]	]	)	O
O	85	86	.	.	.	O

O	88	90	IL	IL	NN	B-NP
O	90	91	-	-	HYPH	O
O	91	93	18	18	CD	B-NP
O	93	94	,	,	,	O
O	95	105	originally	originally	RB	B-VP
O	106	116	identified	identify	VBN	I-VP
O	117	119	as	as	IN	B-PP
O	120	130	interferon	interferon	NN	B-NP
O	130	131	-	-	HYPH	O
O	131	136	gamma	gamma	SYM	B-NP
O	137	145	inducing	induce	VBG	B-VP
O	146	152	factor	factor	NN	B-NP
O	153	154	(	(	(	O
O	154	158	IGIF	IGIF	NN	B-NP
O	158	159	)	)	)	O
O	159	160	,	,	,	O
O	161	163	is	be	VBZ	B-VP
O	164	171	related	related	JJ	B-ADJP
O	172	174	to	to	TO	B-PP
O	175	178	the	the	DT	B-NP
O	179	181	IL	IL	NN	I-NP
O	181	182	-	-	HYPH	B-NP
O	182	183	1	1	CD	I-NP
O	184	190	family	family	NN	I-NP
O	191	193	in	in	IN	B-PP
O	194	199	terms	term	NNS	B-NP
O	200	202	of	of	IN	B-PP
O	203	206	its	its	PRP$	B-NP
O	207	216	structure	structure	NN	I-NP
O	217	219	as	as	RB	B-CONJP
O	220	224	well	well	RB	I-CONJP
O	225	227	as	as	IN	I-CONJP
O	228	231	its	its	PRP$	B-NP
O	232	242	processing	processing	NN	I-NP
O	242	243	,	,	,	O
O	244	252	receptor	receptor	NN	B-NP
O	252	253	,	,	,	O
O	254	260	signal	signal	NN	B-NP
O	261	273	transduction	transduction	NN	I-NP
O	274	281	pathway	pathway	NN	I-NP
O	282	285	and	and	CC	O
O	286	289	pro	pro	AFX	B-NP
O	289	290	-	-	HYPH	I-NP
O	290	302	inflammatory	inflammatory	JJ	I-NP
O	303	313	properties	property	NNS	I-NP
O	313	314	.	.	.	O

O	315	317	IL	IL	NN	B-NP
O	317	318	-	-	HYPH	O
O	318	320	18	18	CD	B-NP
O	321	323	is	be	VBZ	B-VP
O	324	328	also	also	RB	B-ADVP
O	329	341	functionally	functionally	RB	B-ADJP
O	342	349	related	relate	VBN	I-ADJP
O	350	352	to	to	TO	B-PP
O	353	355	IL	IL	NN	B-NP
O	355	356	-	-	HYPH	O
O	356	358	12	12	CD	B-NP
O	358	359	,	,	,	O
O	360	362	as	as	IN	B-SBAR
O	363	365	it	it	PRP	B-NP
O	366	373	induces	induce	VBZ	B-VP
O	374	377	the	the	DT	B-NP
O	378	388	production	production	NN	I-NP
O	389	391	of	of	IN	B-PP
O	392	395	Th1	Th1	NN	B-NP
O	396	405	cytokines	cytokine	NNS	I-NP
O	406	409	and	and	CC	O
O	410	422	participates	participate	VBZ	B-VP
O	423	425	in	in	IN	B-PP
B-Cell	426	430	cell	cell	NN	B-NP
O	430	431	-	-	HYPH	B-NP
O	431	439	mediated	mediate	VBN	I-NP
O	440	446	immune	immune	JJ	I-NP
O	447	459	cytotoxicity	cytotoxicity	NN	I-NP
O	459	460	.	.	.	O

O	461	462	A	A	DT	B-NP
O	463	470	summary	summary	NN	I-NP
O	471	473	is	be	VBZ	B-VP
O	474	478	made	make	VBN	I-VP
O	479	481	of	of	IN	B-PP
O	482	488	recent	recent	JJ	B-NP
O	489	497	advances	advance	NNS	I-NP
O	498	500	in	in	IN	B-PP
O	501	504	the	the	DT	B-NP
O	505	518	understanding	understanding	NN	I-NP
O	519	521	of	of	IN	B-PP
O	522	524	IL	IL	NN	B-NP
O	524	525	-	-	HYPH	O
O	525	527	18	18	CD	B-NP
O	528	537	structure	structure	NN	I-NP
O	537	538	,	,	,	O
O	539	549	processing	processing	NN	B-NP
O	549	550	,	,	,	O
O	551	559	receptor	receptor	NN	B-NP
O	560	570	expression	expression	NN	I-NP
O	571	574	and	and	CC	O
O	575	591	immunoregulatory	immunoregulatory	JJ	B-NP
O	592	601	functions	function	NNS	I-NP
O	601	602	.	.	.	O

O	603	605	It	It	PRP	B-NP
O	606	613	focuses	focus	VBZ	B-VP
O	614	616	on	on	IN	B-PP
O	617	620	the	the	DT	B-NP
O	621	625	role	role	NN	I-NP
O	626	628	of	of	IN	B-PP
O	629	631	IL	IL	NN	B-NP
O	631	632	-	-	HYPH	B-NP
O	632	634	18	18	CD	I-NP
O	635	645	modulation	modulation	NN	I-NP
O	646	648	in	in	IN	B-PP
B-Cancer	649	656	tumours	tumour	NNS	B-NP
O	656	657	,	,	,	O
O	658	668	infections	infection	NNS	B-NP
O	669	672	and	and	CC	O
O	673	683	autoimmune	autoimmune	JJ	B-NP
O	684	687	and	and	CC	I-NP
O	688	700	inflammatory	inflammatory	JJ	I-NP
O	701	709	diseases	disease	NNS	I-NP
O	709	710	.	.	.	O

